May 18, 2016
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will discuss whether to recommend approval for a number of new drugs including ASKA Pharmaceutical’s hepatic encephalopathy treatment rifaximin at its meeting on May 30. The Pharmaceutical...read more